Swiss and French pharmaceutical companies Novartis and Sanofi are pushing for higher medicine prices in Europe. This content ...

European pharmaceutical bosses have called on the EU to increase drug prices towards the much higher levels paid by the US, ...

CEOs from European drugmakers Sanofi and Novartis have inked a letter in The Financial Times urging the European Union to set ...

Swiss and French pharmaceutical companies Novartis and Sanofi argue that the EU should adjust its drug prices to better align with those in the US.

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Novartis will invest $23bn in US-based manufacturing and research and development (R&D) over the next five years, becoming ...

Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...

Novartis says it will build six new manufacturing plants to ... and Merck & Co., best known for its range of vaccines and the ...

European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S. investment. The $200 billion pharma company intends to invest ...

Besides, Novartis, Johnson & Johnson plans to spend $55 billion over four years on domestic manufacturing, research and technology. Merck announced plans to spend $1 billion on a vaccine ...